Effect of RU486, a progesterone antagonist, on uterine progesterone receptor, embryonic development and ovarian function during early pregnancy in pigs
No Thumbnail Available
Authors
Meeting name
Sponsors
Date
Journal Title
Format
Thesis
Subject
Abstract
Progesterone (P4) down-regulates the progesterone receptor (PGR) exclusively within the epithelium of the pig uterus near d 8 of the estrous cycle and pregnancy. How P4 down-regulates the PGR is not understood but is considered necessary for establishment of pregnancy. Progesterone is suggested to increase expression of a cytokine, RANKL, in the uterine epithelium that can activate nuclear factor-kappa B (NF-[kappa]B). Nuclear factor-kappa B is a transcription factor thought to block expression of the PGR, resulting in PGR down-regulation. To test this hypothesis, gilts were injected with a P4 antagonist, RU486, on d 3, 4 and 5 (T1) or on d 6 and d 7 (T2) of pregnancy. The uterus was removed on d 8 and d 12 and the endometrium measured for PGR and RANKL mRNA expression as well as activation of NF-[kappa]B within the uterine epithelium. Treatment of gilts with RU486 increased PGR mRNA expression, indicating that P4 does down-regulated the PGR. Expression of RANKL was greater in gilts injected with RU486 and activation of NF-[kappa]B was not different between treatments on d 8, indicating that RANKL and NF-[kappa]B may not be involved in PGR down-regulation. Activation of NF-[kappa]B did increase on d 12 in treatments that were conducive to normal conceptus development, possibly triggered by conceptus release of NF-kappa B (DNA-binding protein) release of interleukin-1 beta (IL-1[beta]).
Table of Contents
DOI
PubMed ID
Degree
M.S.
Thesis Department
Rights
OpenAccess.
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.